213 related articles for article (PubMed ID: 21966450)
21. HIV in the female genital tract: viral shedding and mucosal immunity.
al-Harthi L; Landay A
Clin Obstet Gynecol; 2001 Jun; 44(2):144-53. PubMed ID: 11344984
[No Abstract] [Full Text] [Related]
22. Mucosal serpin A1 and A3 levels in HIV highly exposed sero-negative women are affected by the menstrual cycle and hormonal contraceptives but are independent of epidemiological confounders.
Rahman S; Rabbani R; Wachihi C; Kimani J; Plummer FA; Ball TB; Burgener A
Am J Reprod Immunol; 2013 Jan; 69(1):64-72. PubMed ID: 22971020
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive proteomic study identifies serpin and cystatin antiproteases as novel correlates of HIV-1 resistance in the cervicovaginal mucosa of female sex workers.
Burgener A; Rahman S; Ahmad R; Lajoie J; Ramdahin S; Mesa C; Brunet S; Wachihi C; Kimani J; Fowke K; Carr S; Plummer F; Ball TB
J Proteome Res; 2011 Nov; 10(11):5139-49. PubMed ID: 21973077
[TBL] [Abstract][Full Text] [Related]
24. Mucosal Blood Group Antigen Expression Profiles and HIV Infections: A Study among Female Sex Workers in Kenya.
Chanzu NM; Mwanda W; Oyugi J; Anzala O
PLoS One; 2015; 10(7):e0133049. PubMed ID: 26186209
[TBL] [Abstract][Full Text] [Related]
25. HIV susceptibility in women: The roles of genital inflammation, sexually transmitted infections and the genital microbiome.
Mtshali A; Ngcapu S; Mindel A; Garrett N; Liebenberg L
J Reprod Immunol; 2021 Jun; 145():103291. PubMed ID: 33647576
[TBL] [Abstract][Full Text] [Related]
26. HIV infection of the genital mucosa in women.
Hladik F; Hope TJ
Curr HIV/AIDS Rep; 2009 Feb; 6(1):20-8. PubMed ID: 19149993
[TBL] [Abstract][Full Text] [Related]
27. Mucosal immune responses in the genital tract of HIV-1-exposed uninfected women.
Hirbod T; Broliden K
J Intern Med; 2007 Jul; 262(1):44-58. PubMed ID: 17598814
[TBL] [Abstract][Full Text] [Related]
28. Natural Immunity to HIV: A Template for Vaccine Strategies.
Fourcade L; Poudrier J; Roger M
Viruses; 2018 Apr; 10(4):. PubMed ID: 29690575
[TBL] [Abstract][Full Text] [Related]
29. Mucosal correlates of protection in HIV-1-exposed sero-negative persons.
Shen R; Smith PD
Am J Reprod Immunol; 2014 Aug; 72(2):219-27. PubMed ID: 24428610
[TBL] [Abstract][Full Text] [Related]
30. Behavior of non-classical soluble HLA class G antigens in human immunodeficiency virus 1-infected patients before and after HAART: comparison with classical soluble HLA-A, -B, -C antigens and potential role in immune-reconstitution.
Murdaca G; Contini P; Setti M; Cagnati P; Lantieri F; Indiveri F; Puppo F
Clin Immunol; 2009 Nov; 133(2):238-44. PubMed ID: 19762282
[TBL] [Abstract][Full Text] [Related]
31. Using safe, affordable and accessible non-steroidal anti-inflammatory drugs to reduce the number of HIV target cells in the blood and at the female genital tract.
Lajoie J; Birse K; Mwangi L; Chen Y; Cheruiyot J; Akolo M; Mungai J; Boily-Larouche G; Romas L; Mutch S; Kimani M; Oyugi J; Ho EA; Burgener A; Kimani J; Fowke KR
J Int AIDS Soc; 2018 Jul; 21(7):e25150. PubMed ID: 30047573
[TBL] [Abstract][Full Text] [Related]
32. HIV-1 gp120 induces TLR2- and TLR4-mediated innate immune activation in human female genital epithelium.
Nazli A; Kafka JK; Ferreira VH; Anipindi V; Mueller K; Osborne BJ; Dizzell S; Chauvin S; Mian MF; Ouellet M; Tremblay MJ; Mossman KL; Ashkar AA; Kovacs C; Bowdish DM; Snider DP; Kaul R; Kaushic C
J Immunol; 2013 Oct; 191(8):4246-58. PubMed ID: 24043886
[TBL] [Abstract][Full Text] [Related]
33. Targeting the genital tract mucosa with a lipopeptide/recombinant adenovirus prime/boost vaccine induces potent and long-lasting CD8+ T cell immunity against herpes: importance of MyD88.
Zhang X; Dervillez X; Chentoufi AA; Badakhshan T; Bettahi I; Benmohamed L
J Immunol; 2012 Nov; 189(9):4496-509. PubMed ID: 23018456
[TBL] [Abstract][Full Text] [Related]
34. Interferon-β induced in female genital epithelium by HIV-1 glycoprotein 120 via Toll-like-receptor 2 pathway acts to protect the mucosal barrier.
Nazli A; Dizzell S; Zahoor MA; Ferreira VH; Kafka J; Woods MW; Ouellet M; Ashkar AA; Tremblay MJ; Bowdish DM; Kaushic C
Cell Mol Immunol; 2019 Feb; 16(2):178-194. PubMed ID: 29553138
[TBL] [Abstract][Full Text] [Related]
35. Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediators.
Dezzutti CS; Hendrix CW; Marrazzo JM; Pan Z; Wang L; Louissaint N; Kalyoussef S; Torres NM; Hladik F; Parikh U; Mellors J; Hillier SL; Herold BC
PLoS One; 2011; 6(8):e23136. PubMed ID: 21858008
[TBL] [Abstract][Full Text] [Related]
36. Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand.
Cohen CR; Duerr A; Pruithithada N; Rugpao S; Hillier S; Garcia P; Nelson K
AIDS; 1995 Sep; 9(9):1093-7. PubMed ID: 8527084
[TBL] [Abstract][Full Text] [Related]
37. Stable CD4 expression and local immune activation in the ectocervical mucosa of HIV-infected women.
Hirbod T; Kimani J; Tjernlund A; Cheruiyot J; Petrova A; Ball TB; Mugo N; Jaoko W; Plummer FA; Kaul R; Broliden K
J Immunol; 2013 Oct; 191(7):3948-54. PubMed ID: 24006463
[TBL] [Abstract][Full Text] [Related]
38. Induction of innate immune responses in the female genital tract: friend or foe of HIV-1 infection?
Firoz Mian M; Ashkar AA
Am J Reprod Immunol; 2011 Mar; 65(3):344-51. PubMed ID: 21223417
[TBL] [Abstract][Full Text] [Related]
39. Natural Immunity to HIV: a delicate balance between strength and control.
Poudrier J; Thibodeau V; Roger M
Clin Dev Immunol; 2012; 2012():875821. PubMed ID: 23304192
[TBL] [Abstract][Full Text] [Related]
40. Soluble human leukocyte antigen -G during pregnancy and infancy in Benin: Mother/child resemblance and association with the risk of malaria infection and low birth weight.
d'Almeida TC; Sadissou I; Milet J; Cottrell G; Mondière A; Avokpaho E; Gineau L; Sabbagh A; Massougbodji A; Moutairou K; Donadi EA; Favier B; Carosella E; Moreau P; Rouas-Freiss N; Courtin D; Garcia A
PLoS One; 2017; 12(2):e0171117. PubMed ID: 28166246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
